379 related articles for article (PubMed ID: 15663222)
1. [Comparative activity of antihistamines on area under dose-response curve from histamine-induced wheal and flare responses in human skin].
Wang RQ; Zhang HY
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2004 Dec; 26(6):634-8. PubMed ID: 15663222
[TBL] [Abstract][Full Text] [Related]
2. A double-blind, randomized, single-dose, crossover comparison of levocetirizine with ebastine, fexofenadine, loratadine, mizolastine, and placebo: suppression of histamine-induced wheal-and-flare response during 24 hours in healthy male subjects.
Grant JA; Riethuisen JM; Moulaert B; DeVos C
Ann Allergy Asthma Immunol; 2002 Feb; 88(2):190-7. PubMed ID: 11868924
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetic and pharmacodynamic modeling of mizolastine in healthy volunteers with an indirect response model.
Deschamps C; Dubruc C; Mentre F; Rosenzweig P
Clin Pharmacol Ther; 2000 Dec; 68(6):647-57. PubMed ID: 11180025
[TBL] [Abstract][Full Text] [Related]
4. Comparative activity of cetirizine and desloratadine on histamine-induced wheal-and-flare responses during 24 hours.
Purohit A; Melac M; Pauli G; Frossard N
Ann Allergy Asthma Immunol; 2004 Jun; 92(6):635-40. PubMed ID: 15237765
[TBL] [Abstract][Full Text] [Related]
5. Comparative wheal and flare study of mizolastine vs terfenadine, cetirizine, loratadine and placebo in healthy volunteers.
Rosenzweig P; Caplain H; Chaufour S; Ulliac N; Cabanis MJ; Thebault JJ
Br J Clin Pharmacol; 1995 Nov; 40(5):459-65. PubMed ID: 8703650
[TBL] [Abstract][Full Text] [Related]
6. Comparative activity of cetirizine and mizolastine on histamine-induced skin wheal and flare responses at 24 h.
Purohit A; Mélac M; Pauli G; Frossard N
Br J Clin Pharmacol; 2002 Mar; 53(3):250-4. PubMed ID: 11874388
[TBL] [Abstract][Full Text] [Related]
7. Relative potency of fexofenadine HCl 180 mg, loratadine 10 mg, and placebo using a skin test model of wheal-and-flare suppression.
Kaliner MA; White MV; Economides A; Crisalida T; Hale M; Liao Y; Christian CD; Georges GC; Woodworth TH; Meeves SG
Ann Allergy Asthma Immunol; 2003 Jun; 90(6):629-34. PubMed ID: 12839321
[TBL] [Abstract][Full Text] [Related]
8. Suppression of the histamine-induced wheal and flare response by fexofenadine HCl 60 mg twice daily, loratadine 10 mg once daily and placebo in healthy Japanese volunteers.
Boyle J; Ridout F; Meadows R; Johnsen S; Hindmarch I
Curr Med Res Opin; 2005 Sep; 21(9):1495-503. PubMed ID: 16197669
[TBL] [Abstract][Full Text] [Related]
9. Mizolastine provides effective symptom relief in patients suffering from perennial allergic rhinitis: a double-blind, placebo-controlled study versus loratadine.
Frèche C; Leynadier F; Horak F; Hide D; Gracia FD; Goos M; Bachert C; Horvath A; Antosova E; Verrecchia M; Soussen PB
Ann Allergy Asthma Immunol; 2002 Sep; 89(3):304-10. PubMed ID: 12269652
[TBL] [Abstract][Full Text] [Related]
10. Comparative therapeutic effect and safety of mizolastine and loratadine in chronic idiopathic urticaria. URTILOR study group.
Leynadier F; Duarte-Risselin C; Murrieta M
Eur J Dermatol; 2000; 10(3):205-11. PubMed ID: 10725819
[TBL] [Abstract][Full Text] [Related]
11. Comparative efficacy of wheal-and-flare suppression among various non-sedating antihistamines and the pharmacologic insights to their efficacy.
Roongapinun S; Wajajamreon S; Fooanant S
J Med Assoc Thai; 2004 May; 87(5):551-6. PubMed ID: 15222528
[TBL] [Abstract][Full Text] [Related]
12. Twenty-four hours of activity of cetirizine and fexofenadine in the skin.
Purohit A; Duvernelle C; Melac M; Pauli G; Frossard N
Ann Allergy Asthma Immunol; 2001 Apr; 86(4):387-92. PubMed ID: 11345280
[TBL] [Abstract][Full Text] [Related]
13. Similar rapid onset of action and magnitude of effect of fexofenadine and cetirizine as assessed by inhibition of histamine-induced wheal-and-flare reaction.
Purohit A; N'Gom AS; Deslandes B; Pauli G; Frossard N
Ann Allergy Asthma Immunol; 2004 Dec; 93(6):562-7. PubMed ID: 15609766
[TBL] [Abstract][Full Text] [Related]
14. Comparison of mizolastine with loratadine in the treatment of perennial allergic rhinitis.
Bellioni P; Catalano B; Cervellera G; Filiaci F; Mira E; Carraro A
Rhinology; 1996 Jun; 34(2):101-4. PubMed ID: 8876072
[TBL] [Abstract][Full Text] [Related]
15. Comparison of the effects of desloratadine and levocetirizine on histamine-induced wheal, flare and itch in human skin.
Denham KJ; Boutsiouki P; Clough GF; Church MK
Inflamm Res; 2003 Oct; 52(10):424-7. PubMed ID: 14520518
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and safety of mizolastine 10 mg in a placebo-controlled comparison with loratadine in chronic idiopathic urticaria: results of the MILOR Study.
Dubertret L; Murrieta Aguttes M; Tonet J
J Eur Acad Dermatol Venereol; 1999 Jan; 12(1):16-24. PubMed ID: 10188144
[TBL] [Abstract][Full Text] [Related]
17. Effects of acrivastine, loratadine and cetirizine on histamine-induced wheal and flare responses.
Bayramgürler D; Bilen N; Apaydýn R; Altintaş L; Sal G; Dökmeci S; Utkan T
Clin Exp Dermatol; 1999 Sep; 24(5):407-11. PubMed ID: 10564333
[TBL] [Abstract][Full Text] [Related]
18. Effects of bepotastine, cetirizine, fexofenadine, and olopatadine on histamine-induced wheal-and flare-response, sedation, and psychomotor performance.
Takahashi H; Ishida-Yamamoto A; Iizuka H
Clin Exp Dermatol; 2004 Sep; 29(5):526-32. PubMed ID: 15347340
[TBL] [Abstract][Full Text] [Related]
19. Suppression of histamine- and allergen-induced skin reactions: comparison of first- and second-generation antihistamines.
dos Santos RV; Magerl M; Mlynek A; Lima HC
Ann Allergy Asthma Immunol; 2009 Jun; 102(6):495-9. PubMed ID: 19558008
[TBL] [Abstract][Full Text] [Related]
20. Time-dependent inhibition of histamine-induced cutaneous responses by oral and intramuscular diphenhydramine and oral fexofenadine.
Jones DH; Romero FA; Casale TB
Ann Allergy Asthma Immunol; 2008 May; 100(5):452-6. PubMed ID: 18517077
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
